New York, NY—January 14, 2010
"Teaching, education and research have always been important to me," said Chitranjan S. Ranawat, M.D., course chairman. "I have given my time and financial resources since the late 1980s to teach Indian orthopaedic surgeons through a fellowship program and continuing education courses. My team and I are proud to say that we have trained 45 orthopaedic surgeons through the Ranawat Orthopaedic Research Foundation. Ninety percent of them have returned to India to practice orthopaedic surgery," he continued.
Joining Dr. Chitranjan Ranawat at the meeting are his sons, Amar S. Ranawat, M.D., who presented on topics including complications of total hip arthroplasty, and Anil S. Ranawat, M.D., who presented on the future direction of robotic surgery. Both are assistant attending orthopedic surgeons at Hospital for Special Surgery.
Douglas E. Padgett, M.D., chief of the Adult Reconstruction and Joint Replacement Division and chief of the Hip Service at Hospital for Special Surgery, moderated the session on Imaging and presented on trends in infection treatment, among other topics. Hospital for Special Surgery has one of the lowest infection rates in the country.
The meeting was presented by Ranawat Orthopaedics and sponsored by Ranawat Orthopaedic Research Foundation.
Since 1986, the Ranawat Orthopaedic Research Foundation has supported orthopaedic research and education in the United States and Asia. With Dr. Chitranjan S. Ranawat as chairman, the foundation has united physicians and scientists in the goal of providing innovative clinical care. In addition, the foundation has trained many orthopaedic surgeons in joint reconstruction surgery.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the eighth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2017-2018). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.